Invitae Corp. engages in the provision of genetic information into mainstream medical practice. The company is headquartered in San Francisco, California and currently employs 1,700 full-time employees. The company went IPO on 2015-02-12. The firm is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. The company offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. The company applies proprietary design, process automation, robotics and bioinformatics software solutions to expand the use and impact of genetic information in sample processing and complex variant interpretation, allowing medical interpretation at scale. The firm also utilizes digital health solutions to improve ease-of-use and to deliver actionable information about risk, prevention, treatment, and monitoring. The firm has served over 3.6 million patients, and over 2.2 million of those patients have made their information available for data sharing.

Industry: Services-Medical Laboratories Peers: Accolade, Inc. AirSculpt Technologies Inc Aveanna Healthcare Holdings Inc CareMax, Inc. Castle Biosciences Inc GeneDx Holdings Corp CVS Health Corp Enhabit Inc InnovAge Holding Corp